With over 300,000 patients undergoing coronary artery bypass graft (CABG) in the United States annually, and saphenous vein graft serving as one of the alternative substitutes to bypass the diseased coronary artery disease, therefore the burden of the saphenous VGS on the healthcare system is of significant concern. Graft occlusion before hospital discharge has been reported to occur in approximately 10% of vein grafts.

An estimated 15% of individuals over 70 will develop peripheral artery disease.****